Accelerate Diagnostics Inc EBITDA margin
¿Qué es el EBITDA margin de Accelerate Diagnostics Inc?
El EBITDA margin de Accelerate Diagnostics Inc es -609.36%
¿Cuál es la definición de EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin de compañías en Sector Health Care en NASDAQ en comparadas con Accelerate Diagnostics Inc
¿Qué hace Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Empresas con ebitda margin similar a Accelerate Diagnostics Inc
- KULR Technology tiene EBITDA margin de -615.27%
- Sorrento Therapeutics tiene EBITDA margin de -614.74%
- Cohen & Steers MLP Income and Opportunity Fund Inc tiene EBITDA margin de -614.53%
- Cue Biopharma Inc tiene EBITDA margin de -612.37%
- Neuropathix tiene EBITDA margin de -612.32%
- Suven Life Sciences tiene EBITDA margin de -609.59%
- Accelerate Diagnostics Inc tiene EBITDA margin de -609.36%
- ProStar tiene EBITDA margin de -608.76%
- ClearVue Technologies tiene EBITDA margin de -608.61%
- e Actiplay SA tiene EBITDA margin de -606.92%
- iBio Inc tiene EBITDA margin de -606.29%
- GlycoMimetics Inc tiene EBITDA margin de -604.90%
- Æterna Zentaris tiene EBITDA margin de -603.74%